Open Access

How much sleep apnea is too much?

  • Denis Martinez1,
  • Cristiane Maria Cassol1Email author and
  • Laura Rahmeier1
Arthritis Research & Therapy200911:409

DOI: 10.1186/ar2690

Published: 15 July 2009

Events of breathing interruption are universally observed during sleep. Togo and colleagues [1], in a study to identify respiratory and movement sleep disorders in chronic fatigue syndrome (CFS) patients with and without fibromyalgia (FM), employed an apnea-hypopnea index (AHI) of 18 events per hour as the normal limit and reported an absence of diagnosable sleep-disordered breathing (SDB). They utilized 18 events per hour as being a threshold 'sufficient to account for excessive daytime sleepiness' and did not report the observed AHI. An institutional task force established five events per hour as the normal AHI limit, based on an ample literature review. The Wisconsin Sleep Cohort Study provides evidence that an AHI ranging from 0.1 to 5 events per hour is enough to increase the risk of developing high blood pressure by 42% [2]. From an AHI of 0.1 to one of 18 events per hour, which cut-off point should be used in FM research? Should it be derived from the emergence of symptoms, from literature reviews, or from hypertension research?

Our group has shown that 50% of women, with any degree of SDB, present with FM [3]. Adrenergic stimulus is a potential cause of FM through the model of sympathetically maintained neuropathic pain syndrome [4, 5] and the central sensitization model [6]. Intermittent hypoxia and arousals induced by SDB might be the missing link between sympathetic hyperactivity and FM [7]. From the Wisconsin Sleep Cohort Study data [2], one can infer that even an AHI >0.1 events per hour may be important when considering the potential effect of SDB on sympathetic activity.

Sympathetic hyperactivity has been associated with metabolic syndrome as well as with sleep apnea. Interestingly, in Table 2 of Togo and colleagues' paper [1] the body mass index of the group with CFS + FM is 3.4 kg/m2 higher than that of the group with CFS alone – equivalent to about 10 kg heavier – a biologically significant difference from the perspective of SDB. The chance of beta error (the error committed in accepting the null hypothesis) in stating that this difference is non-significant in their sample is greater than 50%. Despite the low statistical power, we believe that Togo and colleagues' results support the concept of fragmented sleep having a stressor role and a possible effect on FM. Their data warrant additional research on the influence of sympathetic hyperactivity on FM.

In answering our initial question, we emphasize that any number of SDB events that may influence the autonomic nervous system may be non-trivial. Until evidence-based knowledge is available, we advocate that even the lowest AHI should be reported when probing the role of disturbed sleep within the context of pain syndromes.

Abbreviations

AHI: 

apnea-hypopnea index

CFS: 

chronic fatigue syndrome

FM: 

fibromyalgia

SDB: 

sleep-disordered breathing.

Declarations

Authors’ Affiliations

(1)
Division of Cardiology, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos

References

  1. Togo F, Natelson BH, Cherniack NS, FitzGibbons J, Garcon C, Rapoport DM: Sleep structure and sleepiness in chronic fatigue syndrome with or without coexisting fibromyalgia. Arthritis Res Ther. 2008, 10: R56-10.1186/ar2425.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000, 342: 1378-1384. 10.1056/NEJM200005113421901.View ArticlePubMedGoogle Scholar
  3. Germanowicz D, Lumertz MS, Martinez D, Margarites AF: Sleep disordered breathing concomitant with fibromyalgia syndrome. J Bras Pneumol. 2006, 32: 333-338.PubMedGoogle Scholar
  4. Martinez-Lavin M: Biology and therapy of fibromyalgia: Stress, the stress response system, and fibromyalgia. Arthritis Res Ther. 2007, 9: 216-10.1186/ar2146.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Félix FHC, Fontenele JB: Is fibromyalgia a cardiovascular disease? A comment on Martinez-Lavin's review 'Stress, the stress response system, and fibromyalgia'. Arthritis Res Ther. 2007, 9: 404-10.1186/ar2296.PubMed CentralView ArticlePubMedGoogle Scholar
  6. Staud R: Biology and therapy of fibromyalgia: pain in fibromyalgia syndrome. Arthritis Res Ther. 2006, 8: 208-10.1186/ar1950.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Martinez D, Cassol CM: Fibromyalgia and sleep-disordered breathing: the missing link. Arthritis Res Ther. 2008, 10: 408-10.1186/ar2538.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2009

Advertisement